https://doi.org/10.4081/hmr.v1i6.664

Strategia terapeutica nel sarcoma di Ewing dell'osso tra presente e futuro

Vol. 1 No. 6: XXXIV Congresso Nazionale Società Italiana Ematologia Oncologia Pediatrica
Published: June 22, 2009
Abstract Views: 200
PDF: 2026
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

R. Luksch
support@pagepress.org
M. Podda
Le più moderne strategie terapeutiche basate sulla multidisciplinarietà, hanno permesso di migliorare progressivamente la prognosi dei pazienti affetti da Ewing’s family tumors (EFT). Tuttavia, anche con i trattamenti più aggressivi, il 30% dei pazienti con neoplasia localizzata e il 70% di quelli con presentazione metastatica ancor oggi non sopravvivono.1 I piani di cura applicati attualmente impiegati prevedono una chemioterapia primaria di induzione della remissione, il trattamento locale con chirurgia e/o radioterapia, e successivamente una fase di mantenimento o consolidamento della remissione. Gli studi collaborativi realizzati in Europa e negli Stati Uniti negli ultimi due decenni hanno tenuto in conto una serie di fattori prognostici per impostare i protocolli terapeutici, applicando schemi di terapia diversificati per gruppi di rischio.1

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Luksch, R., & Podda, M. (2009). Strategia terapeutica nel sarcoma di Ewing dell’osso tra presente e futuro. Hematology Meeting Reports (formerly Haematologica Reports), 1(6). https://doi.org/10.4081/hmr.v1i6.664
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).